Strychnine

Strychnine

SCHEMBL1049902

O=C1CC2OCC=C3CN4CC[C@]56c7ccccc7N1C5C2C3CC46.O=[N+]([O-])O

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Strychnine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 14/20 0.90
GLRB P48167 14/20 0.90
CYP3A4 P08684 2/20 0.90
MEN1 O00255 2/20 0.90
KMT2A Q03164 2/20 0.90
TAS2R10 Q9NYW0 2/20 0.90
SCN1A P35498 1/20 0.90
TAS2R46 P59540 1/20 0.90
SCN2A Q99250 1/20 0.90
SCN3A Q9NY46 1/20 0.90
CHRM1 P11229 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Strychnine SCHEMBL1049901 1.00 GLRA1 (0.90) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL29888864 1.00 GLRA1 (0.90) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL29362678 0.95 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL21985190 0.95 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL14047653 0.95 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL29352583 0.95 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL14117483 0.95 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL12549549 0.95 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL93798 0.95 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL14029424 0.95 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1102989-A Antiepilepsy medicine and preparing method TIEXI NEUROPSYCHOSIS HOSPITAL (CN) 1995-05-31 CN claimed
US-3960757-A HYDROPHOBIC TOYO JOZO CO., LTD. (JA) 1976-06-01 US claimed
EP-4653499-A2 SILICONE MATERIAL, SILICONE TUBE, IMPLANT, PHARMACEUTICAL COMPOSITION, AND TEST METHOD FOR AMOUNT OF DRUG RELEASED SHENYANG XINGHUA PHARMACEUTICAL TECHNOLOGY CO., LTD (CN) 2025-11-26 EP disclosed
US-20250205385-A1 SILICONE MATERIAL, SILICONE TUBE, IMPLANT, PHARMACEUTICAL COMPOSITION, AND TEST METHOD FOR AMOUNT OF DRUG RELEASED SHENYANG XINGHUA PHARMACEUTICAL TECHNOLOGY CO., LTD (CN) 2025-06-26 US disclosed
CN-119970889-A Processing method for reducing toxicity of rhizoma arisaematis 河北大学 2025-05-13 CN disclosed
CN-119656097-A Pharmaceutical composition, rod core and implant, and preparation method and application thereof 沈阳药科大学 2025-03-21 CN disclosed
CN-119656096-A Medicine carrying rod core and raw material composition, implant and preparation and application thereof 沈阳药科大学 2025-03-21 CN disclosed
CN-119662025-A Silica gel material and preparation method thereof, silica gel tube and implant, and preparation method and application thereof 沈阳药科大学 2025-03-21 CN disclosed
WO-2025056040-A1 PHARMACEUTICAL COMPOSITION, DRUG-LOADED ROD CORE, IMPLANT, PREPARATION METHOD THEREFOR, AND USE THEREOF 沈阳星华医药科技有限公司 2025-03-20 WO disclosed
WO-2025056039-A1 SILICONE MATERIAL, SILICONE TUBE, IMPLANT AND PREPARATION METHOD THEREFOR, ROD CORE, PERFORATED IMPLANT AND PREPARATION METHOD THEREFOR AND USE THEREOF 沈阳星华医药科技有限公司 2025-03-20 WO disclosed
CN-118716623-B Composition for improving sleep and memory and preparation method and application thereof 浙江衡美健康科技股份有限公司 2024-12-20 CN disclosed
EP-0635218-A1 TASTE MODIFYING METHOD AND BITTER TASTE REDUCING METHOD Kao Corporation (JP) 1995-01-25 EP disclosed
EP-0631787-A2 Method for suppressing bitter taste of oral preparation Kao Corporation (JP) 1995-01-04 EP disclosed
CN-1078906-A Prevent and treat the compound method and the application thereof of tetanus Chinese herbal medicine FANG SIBING (CN) 1993-12-01 CN disclosed
EP-0423524-A2 Propiophenone derivatives and their preparation and pharmaceutical use MARUHO Co., Ltd. (JP) 1991-04-24 EP disclosed
US-4810709-A ANTIHYPOXIC, ANTICONVULSANT RICHTER GEDEON VEGYESZEFI GYAR R.T. (HU) 1989-03-07 US disclosed
US-4677109-A ANTISPASMODIC, ANTIPYRETIC AND ANTIACUTE ALCOHOLIC INTOXICATION Richter Gedeon Vegyeszeti Syar R.T. (HU) 1987-06-30 US disclosed
CN-85106416-A Preparation nitro A Piao vincamine acid derivative and the method that contains the medicinal compositions of this analog derivative 1987-03-18 CN disclosed
US-4494245-A Techniques for repelling predatory animals by the use of aposematic patterns and coloration BURKHEAD NOEL M 1985-01-22 US disclosed
US-3960757-A HYDROPHOBIC TOYO JOZO CO., LTD. (JA) 1976-06-01 US disclosed